Cite

HARVARD Citation

    Kumar, S. et al. (2022). Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial. British journal of haematology. pp. 288-297. [Online]. 
  
Back to record